menu
H2020 Accelerator Program Live Biotherapeutics Manufacturing
Aug 3, 2020

Exeliom Biosciences has been awarded a 2.5M€ H2020 Accelerator Program Grant from the European Innovation Council

This very selective grant will help Exeliom Biosciences obtain first clinical readouts and achieve the manufacturing process scale-up, while protecting its proprietary know-how. With this EIC support, Exeliom Biosciences will be able to greatly accelerate its promising drug development and growth.

Back to news
#Faecalibacterium #GutHealth #HealthResearch #Microbiome #Biotherapeutics #Biotech
Sep 21, 2023
New review on Faecalibacterium published in FEMS Microbiology Reviews explores its potential for human health
#HealthcareInnovation #ClinicalTrial #CDI #Partnership #ExeliomBiosciences #HospicesCivilsdeLyon #MedicalResearch #HealthcareInnovation #ExeliomBiosciences #Biotech #Start-up #Microbiome #Cdiff
Nov 6, 2023
Exeliom Biosciences and Hospices Civils de Lyon announce clinical collaboration in recurrent Clostridioides difficile infection

contact

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.